AN AUTHORITATIVE RESOURCE FOR EVERYTHING ABOUT CANCER
All Articles
Zero Oncologists for 173,000 People: Confronting the Precision Oncology Crisis in Tribal Communities
By Monica Yellowhair, PhD
Dr. Monica Yellowhair examines the cancer care crisis in tribal communities, highlighting barriers to precision oncology access, Indigenous health equity, community navigation, and culturally grounded care.
Zero Oncologists for 173,000 People: Confronting the Precision Oncology Crisis in Tribal Communities
By Monica Yellowhair, PhD
Dr. Monica Yellowhair examines the cancer care crisis in tribal communities, highlighting barriers to precision oncology access, Indigenous health equity, community navigation, and culturally grounded care.
Zero Oncologists for 173,000 People: Confronting the Precision Oncology Crisis in Tribal Communities
By Monica Yellowhair, PhD
Dr. Monica Yellowhair examines the cancer care crisis in tribal communities, highlighting barriers to precision oncology access, Indigenous health equity, community navigation, and culturally grounded care.
Top 5 Takeaways from Dr. Paolo Tarantino on the Future of Antibody-Drug Conjugates in Solid Oncology
By The Cancer News Team
Key insights from Dr. Paolo Tarantino on how antibody-drug conjugates are transforming solid tumor treatment, moving from late-line therapy to frontline and curative-intent strategies.
Top 5 Takeaways from Dr. Paolo Tarantino on the Future of Antibody-Drug Conjugates in Solid Oncology
By The Cancer News Team
Key insights from Dr. Paolo Tarantino on how antibody-drug conjugates are transforming solid tumor treatment, moving from late-line therapy to frontline and curative-intent strategies.
Top 5 Takeaways from Dr. Paolo Tarantino on the Future of Antibody-Drug Conjugates in Solid Oncology
By The Cancer News Team
Key insights from Dr. Paolo Tarantino on how antibody-drug conjugates are transforming solid tumor treatment, moving from late-line therapy to frontline and curative-intent strategies.
Antibody-Drug Conjugates in Solid Tumors: From Magic Bullet to Standard of Care
By Paolo Tarantino, MD, PhD
Antibody-drug conjugates (ADCs) are transforming cancer care by delivering targeted chemotherapy with improved efficacy across multiple solid tumors, redefining treatment from late-line therapy to frontline standard.
Antibody-Drug Conjugates in Solid Tumors: From Magic Bullet to Standard of Care
By Paolo Tarantino, MD, PhD
Antibody-drug conjugates (ADCs) are transforming cancer care by delivering targeted chemotherapy with improved efficacy across multiple solid tumors, redefining treatment from late-line therapy to frontline standard.
Antibody-Drug Conjugates in Solid Tumors: From Magic Bullet to Standard of Care
By Paolo Tarantino, MD, PhD
Antibody-drug conjugates (ADCs) are transforming cancer care by delivering targeted chemotherapy with improved efficacy across multiple solid tumors, redefining treatment from late-line therapy to frontline standard.
Curing the Cancer Does Not Fix the Patient: The Case for Healthcare Transition in Pediatric Oncology
By Mortuma Murry, DNP, CPNP-AC/PC
Why curing cancer isn’t enough—exploring the urgent need for structured healthcare transition programs to support pediatric cancer patients into adulthood and survivorship.
Curing the Cancer Does Not Fix the Patient: The Case for Healthcare Transition in Pediatric Oncology
By Mortuma Murry, DNP, CPNP-AC/PC
Why curing cancer isn’t enough—exploring the urgent need for structured healthcare transition programs to support pediatric cancer patients into adulthood and survivorship.
Curing the Cancer Does Not Fix the Patient: The Case for Healthcare Transition in Pediatric Oncology
By Mortuma Murry, DNP, CPNP-AC/PC
Why curing cancer isn’t enough—exploring the urgent need for structured healthcare transition programs to support pediatric cancer patients into adulthood and survivorship.
The AYA Cancer Gap: Why Adolescents and Young Adults Face Adversity Again
By Archie Bleyer, MD
Adolescent and young adult (AYA) cancer patients face rising incidence, mental health risks, and policy threats. Dr. Archie Bleyer explains why progress in survival is at risk again.
The AYA Cancer Gap: Why Adolescents and Young Adults Face Adversity Again
By Archie Bleyer, MD
Adolescent and young adult (AYA) cancer patients face rising incidence, mental health risks, and policy threats. Dr. Archie Bleyer explains why progress in survival is at risk again.
The AYA Cancer Gap: Why Adolescents and Young Adults Face Adversity Again
By Archie Bleyer, MD
Adolescent and young adult (AYA) cancer patients face rising incidence, mental health risks, and policy threats. Dr. Archie Bleyer explains why progress in survival is at risk again.
Dr. Hina Khan on Closing the Gap: Lung Cancer Screening Disparities and the Fight for Equitable Low-Dose CT Access
By Hina Khan, MD
Lung cancer screening saves lives, yet disparities persist. Dr. Hina Khan explores barriers to low-dose CT access and community-driven solutions to improve early detection and equity.
Dr. Hina Khan on Closing the Gap: Lung Cancer Screening Disparities and the Fight for Equitable Low-Dose CT Access
By Hina Khan, MD
Lung cancer screening saves lives, yet disparities persist. Dr. Hina Khan explores barriers to low-dose CT access and community-driven solutions to improve early detection and equity.
Dr. Hina Khan on Closing the Gap: Lung Cancer Screening Disparities and the Fight for Equitable Low-Dose CT Access
By Hina Khan, MD
Lung cancer screening saves lives, yet disparities persist. Dr. Hina Khan explores barriers to low-dose CT access and community-driven solutions to improve early detection and equity.
Kaposi Sarcoma in 2026: A Disease Controlled in the West, Still Devastating sub-Saharan Africa
By David Aboulafia, MD
Kaposi sarcoma highlights stark global inequities, with effective control in high-income countries but devastating impact in sub-Saharan Africa due to limited ART access, infrastructure gaps, and delayed diagnosis.
Kaposi Sarcoma in 2026: A Disease Controlled in the West, Still Devastating sub-Saharan Africa
By David Aboulafia, MD
Kaposi sarcoma highlights stark global inequities, with effective control in high-income countries but devastating impact in sub-Saharan Africa due to limited ART access, infrastructure gaps, and delayed diagnosis.
Kaposi Sarcoma in 2026: A Disease Controlled in the West, Still Devastating sub-Saharan Africa
By David Aboulafia, MD
Kaposi sarcoma highlights stark global inequities, with effective control in high-income countries but devastating impact in sub-Saharan Africa due to limited ART access, infrastructure gaps, and delayed diagnosis.
Real-World Impact: Applying SABCS 2025 Advances in Community Oncology
By Sara Zhukovsky, MD; Christos Vaklavas, MD
How SABCS 2025 advances are transforming community oncology, with practical strategies to improve breast cancer screening, treatment adherence, survivorship care, and equitable access.
Real-World Impact: Applying SABCS 2025 Advances in Community Oncology
By Sara Zhukovsky, MD; Christos Vaklavas, MD
How SABCS 2025 advances are transforming community oncology, with practical strategies to improve breast cancer screening, treatment adherence, survivorship care, and equitable access.
Real-World Impact: Applying SABCS 2025 Advances in Community Oncology
By Sara Zhukovsky, MD; Christos Vaklavas, MD
How SABCS 2025 advances are transforming community oncology, with practical strategies to improve breast cancer screening, treatment adherence, survivorship care, and equitable access.
The Cervical Cancer Paradox: Disparities and Implementing Strategies in South Asia
By Suchit Shashikumar, MBBS; Jin Mou, MD, MSc, MPH, PhD
Cervical cancer remains preventable, yet disparities in South Asia persist. Explore how HPV vaccination, screening gaps, and community-led innovations can transform outcomes in low-resource settings.
The Cervical Cancer Paradox: Disparities and Implementing Strategies in South Asia
By Suchit Shashikumar, MBBS; Jin Mou, MD, MSc, MPH, PhD
Cervical cancer remains preventable, yet disparities in South Asia persist. Explore how HPV vaccination, screening gaps, and community-led innovations can transform outcomes in low-resource settings.
The Cervical Cancer Paradox: Disparities and Implementing Strategies in South Asia
By Suchit Shashikumar, MBBS; Jin Mou, MD, MSc, MPH, PhD
Cervical cancer remains preventable, yet disparities in South Asia persist. Explore how HPV vaccination, screening gaps, and community-led innovations can transform outcomes in low-resource settings.
Dr. Barbara Goff on HPV-Related Cancers: How Vaccination and Screening Can Eliminate a Global Health Crisis
By Barbara A. Goff, MD
HPV-related cancers are largely preventable through vaccination and screening. Dr. Barbara Goff explores global disparities, advances in HPV testing, and strategies to eliminate cervical cancer worldwide.
Dr. Barbara Goff on HPV-Related Cancers: How Vaccination and Screening Can Eliminate a Global Health Crisis
By Barbara A. Goff, MD
HPV-related cancers are largely preventable through vaccination and screening. Dr. Barbara Goff explores global disparities, advances in HPV testing, and strategies to eliminate cervical cancer worldwide.
Dr. Barbara Goff on HPV-Related Cancers: How Vaccination and Screening Can Eliminate a Global Health Crisis
By Barbara A. Goff, MD
HPV-related cancers are largely preventable through vaccination and screening. Dr. Barbara Goff explores global disparities, advances in HPV testing, and strategies to eliminate cervical cancer worldwide.